Indicated for the treatment of: Advanced Renal Cell Carcinoma (RCC): After failure of sunitinib or sorafenib. Breast Cancer: HR-positive, HER2-negative advanced breast cancer (in combination with Exemestane). Neuroendocrine Tumors (NET): Of pancreatic, gastrointestinal, or lung origin.

Dosage and administration

Strength: 10 mg tablet. Standard Dosage: 10 mg once daily. ⚠️ Administration Instructions: Take at the same time every day. Take consistently either with food or without food (do not alternate). Swallow whole with a glass of water. Do not crush.

Severe hepatic impairment (requires dose reduction). Pregnancy and breastfeeding. Known hypersensitivity to rapamycin derivatives. Uncontrolled active infections.

Most Common: Oral Stomatitis (Mouth Ulcers). Very common within the first 8 weeks. Tip: Use alcohol-free mouthwash or salt/baking soda rinses daily to prevent severity. Other risks: Non-infectious Pneumonitis: Watch for new cough or shortness of breath. Rash, fatigue, and diarrhea. Increased risk of infections (immunosuppression).

Evermil — Everolimus 10 mg, 10 pcs, Glenmark

100% original product

Active ingredient

Everolimus

Manufacturer

Glenmark

Dosage 10 mg

Dosage form Tablets

Tablets per pack 10

Evermil (Everolimus) 10 mg

Name: Evermil
Brand: Glenmark
SKU: PROD-80
Price: 4395 UAH
Availability: InStock

4395₴ ~~5274₴~~ -17%

Evermil 10 mg is a targeted cancer therapy containing Everolimus, an mTOR inhibitor.

Manufacturer: Glenmark Pharmaceuticals (India). A premium generic equivalent of Afinitor.

Mechanism: Stopping the "Engine"

Everolimus binds to a protein called mTOR within cancer cells. mTOR acts like a master switch for cell growth. By blocking it, Evermil stops cancer cells from dividing and cuts off their blood supply (anti-angiogenesis).

✅ Key Benefit: Effective in overcoming resistance to hormonal therapies in breast cancer and other targeted therapies in kidney cancer.

Indicated for the treatment of:

Advanced Renal Cell Carcinoma (RCC): After failure of sunitinib or sorafenib.
Breast Cancer: HR-positive, HER2-negative advanced breast cancer (in combination with Exemestane).
Neuroendocrine Tumors (NET): Of pancreatic, gastrointestinal, or lung origin.

Strength: 10 mg tablet.

Standard Dosage: 10 mg once daily.

⚠️ Administration Instructions:

Take at the same time every day.
Take consistently either with food or without food (do not alternate).
Swallow whole with a glass of water. Do not crush.

Severe hepatic impairment (requires dose reduction).
Pregnancy and breastfeeding.
Known hypersensitivity to rapamycin derivatives.
Uncontrolled active infections.

Most Common: Oral Stomatitis (Mouth Ulcers).

Very common within the first 8 weeks. Tip: Use alcohol-free mouthwash or salt/baking soda rinses daily to prevent severity.

Other risks:

Non-infectious Pneumonitis: Watch for new cough or shortness of breath.
Rash, fatigue, and diarrhea.
Increased risk of infections (immunosuppression).

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 02.03.2026

Active ingredient

Everolimus

Manufacturer

Glenmark

Dosage 10 mg

Dosage form Tablets

Tablets per pack 10

100% original product

Delivery across Ukraine

Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Evermil (Everolimus) 10 mg

What Customers Say

No reviews yet

Contact us

Request a call